$145 Trillion is the total value of Baillie Gifford's 824 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CVNA | New | Carvana | $1,269,606,000 | – | 5,691,766 | +100.0% | 0.87% | – |
| BEKE | New | KE Holdings ADRadr | $902,932,000 | – | 14,729,730 | +100.0% | 0.62% | – |
| SGEN | New | Seagen Inc | $644,781,000 | – | 3,294,909 | +100.0% | 0.44% | – |
| DDOG | New | Datadog | $567,699,000 | – | 5,556,957 | +100.0% | 0.39% | – |
| SNOW | New | Snowflake Inc | $250,492,000 | – | 997,975 | +100.0% | 0.17% | – |
| CVAC | New | CureVac N.V. - Converted at IPO | $181,381,000 | – | 3,896,475 | +100.0% | 0.12% | – |
| LMND | New | Lemonade Inc | $157,442,000 | – | 3,166,585 | +100.0% | 0.11% | – |
| New | Snowflake, Inc. Class B Common | $75,805,000 | – | 302,011 | +100.0% | 0.05% | – | |
| CLDR | New | Cloudera Inc | $61,879,000 | – | 5,682,150 | +100.0% | 0.04% | – |
| LPSN | New | LivePerson Inc | $60,068,000 | – | 1,155,372 | +100.0% | 0.04% | – |
| BLI | New | Berkeley Lights Inc | $46,225,000 | – | 605,343 | +100.0% | 0.03% | – |
| BEPC | New | Brookfield Renewable | $44,195,000 | – | 754,183 | +100.0% | 0.03% | – |
| RLAY | New | Relay Therapeutics Inc | $42,506,000 | – | 5,664,921 | +100.0% | 0.03% | – |
| TTM | New | Tata Motors Ltd ADR | $20,556,000 | – | 2,261,383 | +100.0% | 0.01% | – |
| KDNY | New | Chinook Therapeutics | $10,366,000 | – | 4,265,980 | +100.0% | 0.01% | – |
| AMSC | New | American Superconductor Corp | $7,490,000 | – | 517,270 | +100.0% | 0.01% | – |
| MYOK | New | Myokardia Inc | $2,862,000 | – | 20,993 | +100.0% | 0.00% | – |
| AMWL | New | American Well Corp Class A | $2,837,000 | – | 95,700 | +100.0% | 0.00% | – |
| SMMT | New | Summit Therapeutics New Listing | $1,281,000 | – | 372,261 | +100.0% | 0.00% | – |
| XPEV | New | Xpeng Inc ADRadr | $1,608,000 | – | 80,110 | +100.0% | 0.00% | – |
| ACET | New | Adicet Bio Inc | $2,159,000 | – | 181,626 | +100.0% | 0.00% | – |
| VYNE | New | Vyne Therapeutics Inc | $655,000 | – | 395,049 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-12
About Baillie Gifford
Baillie Gifford is a well-known investment management firm that has been in operation for over a century. The company was founded in 1908 and is headquartered in Edinburgh, Scotland. Baillie Gifford has a reputation for being a long-term investor, with a focus on growth-oriented companies. The firm manages a range of investment strategies, including equities, fixed income, and multi-asset portfolios.
Baillie Gifford has a team of experienced investment professionals, including its CEO, Andrew Telfer, and its Chief Investment Officer, Charles Plowden. The firm's investment philosophy is based on the belief that long-term investing is the best way to achieve superior returns. Baillie Gifford's investment process involves in-depth research and analysis of companies, with a focus on identifying those with strong growth potential.
One of the key strengths of Baillie Gifford is its focus on innovation. The firm has a history of investing in companies that are disrupting traditional industries, such as Tesla and Amazon. Baillie Gifford also has a strong track record of investing in emerging markets, such as China and India.
Overall, Baillie Gifford is a respected investment management firm with a long history of delivering strong returns for its clients. The firm's focus on long-term investing and innovation has helped it to stand out in a crowded market, and its experienced team of investment professionals is well-equipped to navigate the challenges of today's investment landscape.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Amazon.Com | 42 | Q3 2023 | 10.0% |
| Tesla Motors | 42 | Q3 2023 | 10.7% |
| Illumina | 42 | Q3 2023 | 6.6% |
| Baidu.com Sponsored ADR | 42 | Q3 2023 | 11.6% |
| Meta Platforms Inc | 42 | Q3 2023 | 5.0% |
| MercadoLibre | 42 | Q3 2023 | 7.3% |
| Intuitive Surgical | 42 | Q3 2023 | 3.5% |
| Moody's Corp | 42 | Q3 2023 | 1.4% |
| MasterCard Inc-Class A | 42 | Q3 2023 | 1.9% |
| Workday Inc | 42 | Q3 2023 | 1.4% |
View Baillie Gifford's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Oddity Tech Ltd | September 07, 2023 | 4,914,661 | 10.9% |
| Roblox Corp | September 07, 2023 | 28,106,215 | 5.0% |
| SiteOne Landscape Supply, Inc. | August 03, 2023 | 2,234,985 | 5.0% |
| UPWORK, INC | August 03, 2023 | 6,565,230 | 4.9% |
| CHINOOK THERAPEUTICS, INC. | August 01, 2023 | 844,684 | 2.0% |
| MELI Kaszek Pioneer CorpSold out | July 05, 2023 | 0 | 0.0% |
| Abcam plc | June 08, 2023 | 11,331,726 | 4.9% |
| CARVANA CO. | June 06, 2023 | 61,989 | 0.1% |
| EverQuote, Inc. | May 03, 2023 | 1,358,439 | 5.0% |
| CEMEX SAB DE CV | March 03, 2023 | 752,914,110 | 5.0% |
View Baillie Gifford's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-04 |
| SC 13G/A | 2024-04-04 |
| SC 13G/A | 2024-03-07 |
| SC 13G/A | 2024-03-06 |
| SC 13G/A | 2024-02-07 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-30 |
| SC 13G/A | 2024-01-30 |
| SC 13G/A | 2024-01-30 |
View Baillie Gifford's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.